Yahoo Poland Wyszukiwanie w Internecie

Search results

  1. 6 mar 2023 · This review points to a global increase in ADHD symptoms and has implications for the prevalence and management of ADHD during the post-pandemic recovery. Keywords: ADHD, Covid-19, pandemic, meta-analysis, children, adolescents, inattention, hyperactivity, impulsivity.

  2. 12 lip 2024 · More specifically, low parental anxiety at T1 positively moderated the association between the COVID-19 impact on children at T1 and child internalizing problems at T2. The results highlight the importance of providing on-going psychological support for children and adolescents with ADHD and emphasize the need to aid parents in effectively ...

  3. 1 sty 2024 · The variables analyzed in this SR are related to the domains affected by ADHD, such as patients’ behavior (e.g., depression/sadness, inattention, anxiety, irritability/aggressiveness); relationship (e.g., family and peers); changes (e.g., sleep, medication treatment, media use, remote learning).

  4. 1 sty 2024 · Adolescents with ADHD reported higher T3 parent-reported depressive symptoms (β = 0.13, p = 0.022). Baseline COVID-19 related stress was associated with T3 increased anxiety (ab = 0.10) and self and parent report depression (ab = 0.07 and ab = 0.09 respectively) via brooding rumination at T2.

  5. 25 kwi 2023 · This study aimed to investigate the longitudinal associations between childrens COVID-19 stress and ADHD symptom severity, oppositional symptoms, negative affect, anxiety, depression, and irritability in Australian children aged 5 to 17 years with ADHD at two-time points during the pandemic.

  6. 8 gru 2023 · Our Mendelian randomization (MR) analyses found that ADHD confers a causal effect on hospitalized COVID-19 (odds ratio (OR): 1.36, 95% confidence interval (CI): 1.10–1.69). TS confers a causal effect on critical COVID-19 (OR: 1.14, 95% CI: 1.04–1.25).

  7. 22 lip 2020 · The DSM-5 diagnosis in the pediatric population requires the presence of ≥6 symptoms of inattention and/or ≥6 symptoms of hyperactivity/impulsivity (in adults, ≥5 symptoms of each), that have persisted for ≥6 months to a degree that is inconsistent with the developmental level and negatively impacts social and academic/occupational activities, a...